, /PRNewswire/ -- BC Platforms (BCP), a planetary person successful healthcare information absorption and analytics, contiguous announced that, unneurotic with Finland's Euformatics and Hungary's Oncompass Medicine, the BCP-led concern has present successfully been awarded declaration for the 2nd signifier of processing standardized oncology workflows for a purchaser consortium of 7 starring cardinal European hospitals*, represented by the Medical University Graz. This follows connected from the announcement of 18 May 2022 astir the 3 companies forming a concern to present signifier 1 of this 'Instand-NGS4P' project**.
Instand-NGS4P is simply a Horizon 2020 funded task that shares BC Platforms imaginativeness for improving crab patients' diagnostics. This is achieved by processing and providing integrated and standardized workflows for Next Generation Sequencing (NGS) and integrating accusation from crab cistron testing, pharmacogenetics investigating and e-medication, to enactment aesculapian determination making. The programme volition run, with 3 phases, until May 2025 with a full pre-commercial procurement fund of astir EUR 8 million (around USD 8.2 million).
BC Platforms, Euformatics, and Oncompass Medicine, person been moving connected designing the solution. After thorough reappraisal of submitted reports from assorted providers for Phase 1, and the applications for Phase 2 regarding prototyping, the BC Platforms led concern has been awarded the Phase 2 contract. The operation of existing IP and expertise successful areas specified arsenic genomic information management, variant interpretation, NGS information prime control, and precision oncology, was cardinal to the concern being awarded the contract.
Kurt Zatloukal, Professor of Pathology astatine the Medical University Graz, said, "Phase 1 of this important task to present innovative NGS workflows, driven by diligent and objective needs, has travel a agelong mode since our past announcement successful May. The consortium of BC Platforms, Euformatics and Oncompass Medicine was selected from respective highly competitory applications, which were assessed successful a multi-step peer-reviewed process. We're looking guardant to continuing this stimulating collaboration successful signifier two."
Tero Silvola, CEO of BC Platforms, said, "I'm delighted that the outstanding prime of the enactment connected this important Horizon 2020 funded project, resulting from our adjacent concern with the talented teams astatine Euformatics, and Oncompass Medicine, has been recognised with a declaration for signifier two. This is astir helping specify the objective practices for oncology and precision medicine for years to come. We are arrogant that our genomic information absorption level is playing a portion successful making healthcare better, alongside Euformatics's expertise successful variant mentation and prime control, and Oncompass Medicine's beardown publication to the e-medication portion of the program."
Tommi Kaasalainen, CEO of Euformatics, said, "We're delighted with different triumph successful concern with BC Platforms, having deployed objective solutions unneurotic successful North America, Europe, and Asia. Oncompass Medicine has been an fantabulous summation to the partnership, providing important value. We'll beryllium continuing with this winning trio successful signifier 2 of the Instand-NGS4P program, which volition physique connected apical of the Euformatics Genomics Hub offering successful adjacent collaboration with starring European healthcare institutions."
Professor Dr. Istvan Petak, Founder and CEO of Oncompass Medicine, said, "I said backmost successful May we're looking guardant to pushing the envelope, and I'm delighted with however acold we've been capable to go, moving intimately with our partners. We privation to supply an end-to-end solution for oncologists to find the close targeted therapy for each crab diligent based connected the full analyzable molecular illustration of their tumor. This concern volition marque it casual for hospitals to deploy amended NGS services, and patients person amended treatments, agelong aft the task is completed."
The 2nd signifier of the task starts now, with results owed successful January 2024. The infirmary purchasing consortium volition past measure the output of each signifier 2 contractors and prime those to proceed to signifier 3 to yet deploy and integrate successful 2025 2 standardized NGS workflows arsenic the effect of the Instand-NGS4P program.
* The consortium is formed by hospitals from the Medical University of Graz successful Austria, University of Florence and University of Milano-Bicocca successful Italy, Erasmus University Medical Center successful the Netherlands, Christian-Albrecht University of Kiel and St. Anna Children's Cancer Research Institute successful Germany, and the Centre Léon Bérard successful France.
** The task is co-funded by the European Union Grant Agreement fig 874719.
About BC Platforms
BC Platforms is simply a planetary person successful gathering information networks for the beingness sciences manufacture and provides versatile exertion platforms for personalised medicine, accelerating the translation of innovations into objective practice. We person analyzable biologic accusation collected successful the healthcare mounting into actionable insights. With our innovative exertion we are creating a diligent centric infinity loop betwixt the beingness sciences and healthcare sectors. Data we generate, harmonise, and manage, from divers biobanks and healthcare institutions, is made accessible for pharmaceutical and biotech companies to heighten their halfway strengths successful probe and development. In parallel, we alteration stratification of patients towards targeted therapies, delivering connected the committedness of much personalized healthcare.
Our precocious performing genomic information find and analytics level enables flexible information integration, unafraid analysis, and mentation of molecular and objective information. We person developed a Global Data Partner Network, BCRQUEST.com, which allows entree to high-quality real-world data. This rapidly increasing web has a footprint crossed galore sites, including networks of large hospitals, covering 20 countries connected 5 continents, providing modular of attraction information for implicit 23 cardinal patients. Our platforms seamlessly facilitate entree to highly enriched information for pharmaceutical probe and development.
Founded successful 1997 from a MIT Whitehead task spinoff, we person a beardown technological practice underpinned by implicit 25 years of moving successful adjacent collaboration with a web of starring researchers, developers, and manufacture partners. We person planetary operations with our office successful Zurich, Switzerland, R&D successful Espoo, Finland, and Singapore, arsenic good arsenic a beingness successful London and Boston. For much information, sojourn our website and travel america connected LinkedIn.
Cision
View archetypal content:https://www.prnewswire.com/news-releases/partnership-of-bc-platforms-euformatics-and-oncompass-medicine-selected-to-deliver-standardized-oncology-ngs-workflows-for-seven-major-european-hospitals-301690575.html
SOURCE BC Platforms
English (US)